Synopsys, Inc. $SNPS Shares Sold by Rheos Capital Works Inc.

Rheos Capital Works Inc. trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 50.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,000 shares of the semiconductor company’s stock after selling 12,000 shares during the quarter. Rheos Capital Works Inc.’s holdings in Synopsys were worth $5,921,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SNPS. Alpine Bank Wealth Management grew its holdings in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after buying an additional 25 shares in the last quarter. Independence Bank of Kentucky lifted its stake in shares of Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares in the last quarter. SOA Wealth Advisors LLC. acquired a new position in Synopsys during the third quarter worth about $28,000. Princeton Global Asset Management LLC grew its stake in Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 53 shares in the last quarter. Finally, AlphaQuest LLC grew its stake in Synopsys by 423.1% during the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock valued at $35,000 after acquiring an additional 55 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.62% of the stock is currently owned by insiders.

Synopsys Trading Up 3.0%

NASDAQ SNPS opened at $508.77 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a market capitalization of $97.34 billion, a P/E ratio of 63.68, a PEG ratio of 4.11 and a beta of 1.12. The firm’s 50-day moving average is $440.92 and its two-hundred day moving average is $503.83. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the firm earned $3.40 EPS. The business’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. BNP Paribas initiated coverage on shares of Synopsys in a research note on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 target price on the stock. Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Morgan Stanley boosted their price objective on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Finally, Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and dropped their target price for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. Eleven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $562.13.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.